Statistics for Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia
Total visits
| views | |
|---|---|
| Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia | 86 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
File Visits
| views | |
|---|---|
| MAHLANGU_et_al-2012-Journal_of_Thrombosis_and_Haemostasis.pdf(legacy) | 64 |
| MAHLANGU_et_al-2012-Journal_of_Thrombosis_and_Haemostasis.pdf | 10 |
Top country views
| views | |
|---|---|
| South Africa | 30 |
| United States | 26 |
| China | 22 |
| Germany | 6 |
| Austria | 2 |
| Spain | 2 |
| Romania | 2 |
Top city views
| views | |
|---|---|
| Wilmington | 10 |
| Beijing | 6 |
| Johannesburg | 6 |
| Changsha | 4 |
| Denver | 4 |
| Overland Park | 4 |
| Pretoria | 4 |
| Absecon | 2 |
| Campia | 2 |
| Des Moines | 2 |
| Dongguan | 2 |
| Jinan | 2 |
| Lanzhou | 2 |
| Shanghai | 2 |
| Tianjin | 2 |
| Vienna | 2 |
| Woodbridge | 2 |
| Ürümqi | 2 |